rs1800428

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000520.6(HEXA):​c.9C>T​(p.Ser3Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0424 in 1,613,708 control chromosomes in the GnomAD database, including 1,833 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 131 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1702 hom. )

Consequence

HEXA
NM_000520.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.521
Variant links:
Genes affected
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
HEXA-AS1 (HGNC:25810): (HEXA antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 15-72375964-G-A is Benign according to our data. Variant chr15-72375964-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 93193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-72375964-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.521 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HEXANM_000520.6 linkc.9C>T p.Ser3Ser synonymous_variant Exon 1 of 14 ENST00000268097.10 NP_000511.2 P06865-1A0A0S2Z3W3
HEXANM_001318825.2 linkc.9C>T p.Ser3Ser synonymous_variant Exon 1 of 14 NP_001305754.1 P06865H3BP20B4DVA7
HEXANR_134869.3 linkn.51C>T non_coding_transcript_exon_variant Exon 1 of 11
HEXA-AS1NR_027262.1 linkn.-149G>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HEXAENST00000268097.10 linkc.9C>T p.Ser3Ser synonymous_variant Exon 1 of 14 1 NM_000520.6 ENSP00000268097.6 P06865-1
ENSG00000260729ENST00000379915.4 linkn.9C>T non_coding_transcript_exon_variant Exon 1 of 16 2 ENSP00000478716.1 A0A087WUJ7

Frequencies

GnomAD3 genomes
AF:
0.0329
AC:
5011
AN:
152202
Hom.:
132
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00789
Gnomad AMI
AF:
0.111
Gnomad AMR
AF:
0.0252
Gnomad ASJ
AF:
0.0179
Gnomad EAS
AF:
0.114
Gnomad SAS
AF:
0.0510
Gnomad FIN
AF:
0.0210
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0441
Gnomad OTH
AF:
0.0320
GnomAD3 exomes
AF:
0.0415
AC:
10372
AN:
250098
Hom.:
289
AF XY:
0.0427
AC XY:
5777
AN XY:
135386
show subpopulations
Gnomad AFR exome
AF:
0.00791
Gnomad AMR exome
AF:
0.0269
Gnomad ASJ exome
AF:
0.0190
Gnomad EAS exome
AF:
0.113
Gnomad SAS exome
AF:
0.0472
Gnomad FIN exome
AF:
0.0231
Gnomad NFE exome
AF:
0.0431
Gnomad OTH exome
AF:
0.0395
GnomAD4 exome
AF:
0.0433
AC:
63351
AN:
1461388
Hom.:
1702
Cov.:
31
AF XY:
0.0438
AC XY:
31878
AN XY:
727000
show subpopulations
Gnomad4 AFR exome
AF:
0.00618
Gnomad4 AMR exome
AF:
0.0263
Gnomad4 ASJ exome
AF:
0.0172
Gnomad4 EAS exome
AF:
0.139
Gnomad4 SAS exome
AF:
0.0467
Gnomad4 FIN exome
AF:
0.0241
Gnomad4 NFE exome
AF:
0.0432
Gnomad4 OTH exome
AF:
0.0395
GnomAD4 genome
AF:
0.0329
AC:
5007
AN:
152320
Hom.:
131
Cov.:
32
AF XY:
0.0325
AC XY:
2420
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.00786
Gnomad4 AMR
AF:
0.0251
Gnomad4 ASJ
AF:
0.0179
Gnomad4 EAS
AF:
0.114
Gnomad4 SAS
AF:
0.0508
Gnomad4 FIN
AF:
0.0210
Gnomad4 NFE
AF:
0.0441
Gnomad4 OTH
AF:
0.0317
Alfa
AF:
0.0382
Hom.:
74
Bravo
AF:
0.0317
Asia WGS
AF:
0.0680
AC:
236
AN:
3478
EpiCase
AF:
0.0433
EpiControl
AF:
0.0453

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 01, 2012
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 15, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Tay-Sachs disease Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 20, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
Dec 16, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 19, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
10
DANN
Benign
0.93
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1800428; hg19: chr15-72668305; COSMIC: COSV51505476; COSMIC: COSV51505476; API